Literature DB >> 16157239

Fermented soy product supplemented with isoflavones affected fat depots in juvenile rats.

Marla S J Manzoni1, Elizeu A Rossi, Iracilda Z Carlos, Regina C Vendramini, Ana C G O Duarte, Ana R Dâmaso.   

Abstract

OBJECTIVES: This study investigated the effects of soy product fermented by Enterococcus faecium and Lactobacillus jugurti supplemented with isoflavones on adipose tissue, blood lipid, and glucose levels on juvenile rats.
METHODS: Rats were fed a cholesterol-enriched diet for 3 wk as a preliminary treatment to create hypercholesterolemia. They were then fed a chow diet (HC), a chow diet plus fermented soy product supplemented with isoflavones (HCFI), a chow diet plus placebo (HCP), or a chow diet plus placebo supplemented with isoflavones (HCPI), respectively, for an additional 3 wk.
RESULTS: The beneficial effects of fermented soy product supplemented with isoflavones on epididymal (EPI) and retroperitoneal (RET) fat pads was likely due to isoflavones because adipocyte circumference (micrometers) in the HC group was significantly larger (EPI: 105.66 +/- 13.36; RET: 134.95 +/- 25.40) than that in the HCFI group (EPI: 93.17 +/- 12.80; RET: 108.62 +/- 15.50) and HCPI group (EPI: 93.06 +/- 15.10; RET: 112.34 +/- 18.21). The probiotic micro-organism accentuated the antilipogenic effect of isoflavones on RET (HCFI: 108.62 +/- 15.50 micrometers versus HCPI: 112.34 +/- 18.21 micrometers). Moreover, the fermented product increased glucose concentration similar to that in the chow group but did not change blood lipids.
CONCLUSION: This product may offer new approaches to obesity prevention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157239     DOI: 10.1016/j.nut.2005.02.007

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  8 in total

1.  Protective effects of green tea against hepatic injury induced by high-cholesterol diet in rats: histopathological analysis, oxidative DNA damage and COX-2 expression.

Authors:  Bárbara B de Moraes; Gabriela Pasquini; Odair Aguiar; Andréa P B Gollücke; Silvia S M Ihara; Neuli M Tenorio; Monica L Andersen; Rodrigo R Catharino; Regina Celia Spadari-Bratfisch; Daniel Araki Ribeiro
Journal:  Hepatol Int       Date:  2011-06-21       Impact factor: 6.047

2.  Soy isoflavones reduce electronegative low-density lipoprotein (LDL(-)) and anti-LDL (-) autoantibodies in experimental atherosclerosis.

Authors:  Nágila Raquel Teixeira Damasceno; Elaine Apolinário; Fabiana Dias Flauzino; Irene Fernandes; Dulcineia Saes Parra Abdalla
Journal:  Eur J Nutr       Date:  2007-01-30       Impact factor: 5.614

3.  A cross-over trial on soy intake and serum leptin levels in women with metabolic syndrome.

Authors:  Leila Azadbakht; Ahmad Esmaillzadeh
Journal:  J Res Med Sci       Date:  2010-11       Impact factor: 1.852

4.  Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver.

Authors:  Claudia C Alves; Dan L Waitzberg; Laila S de Andrade; Laís Dos Santos Aguiar; Milene B Reis; Camila C Guanabara; Odair A Júnior; Daniel A Ribeiro; Priscila Sala
Journal:  Front Microbiol       Date:  2017-10-17       Impact factor: 5.640

5.  Habitual Miso (Fermented Soybean Paste) Consumption Is Associated with a Low Prevalence of Sarcopenia in Patients with Type 2 Diabetes: A Cross-Sectional Study.

Authors:  Fuyuko Takahashi; Yoshitaka Hashimoto; Ayumi Kaji; Ryosuke Sakai; Yuka Kawate; Takuro Okamura; Noriyuki Kitagawa; Hiroshi Okada; Naoko Nakanishi; Saori Majima; Takafumi Senmaru; Emi Ushigome; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  Nutrients       Date:  2020-12-28       Impact factor: 5.717

6.  Habitual Miso (Fermented Soybean Paste) Consumption Is Associated with Glycemic Variability in Patients with Type 2 Diabetes: A Cross-Sectional Study.

Authors:  Fuyuko Takahashi; Yoshitaka Hashimoto; Ayumi Kaji; Ryosuke Sakai; Akane Miki; Takuro Okamura; Noriyuki Kitagawa; Hiroshi Okada; Naoko Nakanishi; Saori Majima; Takafumi Senmaru; Emi Ushigome; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  Nutrients       Date:  2021-04-28       Impact factor: 5.717

7.  Effects of a ferment soy product on the adipocyte area reduction and dyslipidemia control in hypercholesterolemic adult male rats.

Authors:  Nadia Carla Cheik; Elizeu Antônio Rossi; Ricardo Luís Fernandes Guerra; Neuli Maria Tenório; Cláudia Maria Oller do Nascimento; Fabiana Pavan Viana; Marla Simone Jovenasso Manzoni; Iracilda Zeponni Carlos; Patrícia Leão da Silva; Regina Célia Vendramini; Ana Raimunda Dâmaso
Journal:  Lipids Health Dis       Date:  2008-12-16       Impact factor: 3.876

Review 8.  Role of dietary soy protein in obesity.

Authors:  Manuel T Velasquez; Sam J Bhathena
Journal:  Int J Med Sci       Date:  2007-02-26       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.